All News

As the Republican-led Congress wrestles with the daunting challenge of developing comprehensive health care legislation to replace the Affordable Care Act, specialty organizations-including those representing urology-are working to influence the ultimate outcome.

Transrectal saturation biopsy resulted in higher rates of disease reclassification compared with magnetic resonance (MR) fusion biopsy plus extended sextant prostate biopsy in patients with low-risk prostate cancer on active surveillance.

In this interview, newly elected AUA President J. Brantley Thrasher, MD, discusses the organization’s expanded efforts in advocacy, research, and education.

Maternal postpartum depression (PPD) is a widely studied and discussed phenomenon, whereas much less is known about the concept of paternal PPD. Nonetheless, recent studies have indicated that depression in new fathers is a significant public health concern.

Informed consent in medicine generally refers to one of two things: the process by which a provider obtains consent through discussion of risks, benefits, and alternatives with patients, and the actual form that is signed by the physician and the patient. Both are critical pieces to any medical malpractice litigation where a claim for lack of informed consent has been pled.

A study aimed at further elucidating the mechanism of action of sipuleucel-T (Provenge) in advanced prostate cancer provides fairly convincing evidence that the immunotherapy agent induces T-cell responses in humans, says Charles G. Drake, MD, PhD.

Patients newly diagnosed with prostate cancer show race-related differences in what men perceive as important factors in their treatment decision-making process.

Among the AUA annual meeting take-home messages in basic science is that the immune co-stimulatory molecule B7-H4 is highly expressed in the luminal subtype of bladder urothelial carcinoma and is associated with poor survival.

The safety and viability of outpatient percutaneous nephrolithotomy and predictors of success after shock wave lithotripsy were among the research highlights in endourology/stones at the AUA annual meeting.

Other key studies in trauma/reconstruction from AUA 2017 evaluated transcorporal artificial urinary sphincter placement using local tunica albuginea flaps and a model for predicting the risk of urethral stricture recurrence after anterior urethroplasty.

Other pipeline developments include a new company formed to develop OAB treatments, a phase III urothelial cancer study meeting its primary endpoint, the formation of a partnership to study RCC treatment, and more.

As some assets appreciate in value and others lose value, your portfolio’s allocation changes. Rebalancing is the remedy for asset drift and an important part of maintaining a healthy investment portfolio.

Henry Rosevear, MD, discusses his experience with the On-Demand Course Pass for this year’s AUA annual meeting, including the two On-Demand courses he found most informative.

Findings from a recent study also suggest that obesity may be a factor to consider for men with prostate cancer deciding between active surveillance and definitive treatment.

Urology Times reached out to three urologists (selected randomly) and asked them each the following: Are anticholinergic drugs overused in treating OAB?

Men who experience a prostate biopsy-related complication are more likely to seek active treatment for clinically localized prostate cancer than those who do not experience a complication, according to findings from a review of the Surveillance, Epidemiology, and End Results Medicare linked database.

A new study suggests that surgical care for renal trauma cases is evolving in two different directions: Endovascular procedures have become more common for blunt trauma, supplanting nephrectomy and laceration repair.

Results of a retrospective case-cohort study show no significant differences in surgical outcomes among men who did and did not have preoperative magnetic resonance imaging of the prostate prior to radical prostatectomy for prostate cancer.

"The health care field does not show any signs of slowing in pace or growth, and as many people view health care as a service, it is important to strive for an environment that is high in quality, care, support, and acceptance," writes SUNA's Amy Hull, MSN, WHNP-BC.

Continuing its participation in the Choosing Wisely campaign, the AUA has added five new recommendations about tests and treatments that physicians and patients should question.

“We strongly believe that PSA-based prostate cancer screening should be made available, especially to men 70 years and older to decrease the morbidity and mortality of prostate cancer,” write Navin Shah, MD, and Vladimir Ioffe, MD.

A 3-month old baby born with atypical genitalia has an XY karyotype. The baby undergoes diagnostic laparoscopy. The baby is doing clinically well without medication.

“Abiraterone should change the treatment paradigm for patients with newly diagnosed metastatic prostate cancer and largely displaces chemotherapy from the current paradigm,” said Sumanta Kumar Pal, MD.

Administering bone supportive therapy within 1 month prior to starting radium Ra 223 dichloride (Xofigo) may increase the likelihood of achieving pain palliation with the radionuclide therapy and reduce the chance of pain flare, according to the findings of a retrospective study.